Evidence map›Paper›PMID 41785329›Full record

ArticleBlood2026

Oxidized PDI promotes thrombus formation in oxidative stress.

Moua Yang, Osamede C Owegie, Anika Patel, Quinn P Kennedy, James T Flaumenhaft, Mathivanan Chinnaraj, Nathan Ponzar, Emmy M Fulcidor, Mario C Rico, Amit Bhowmik and 6 more

Abstract read
In one paragraph

Article in Blood, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Moua YangBloodworks Northwest Research Institute, Seattle, WA.ORCID 0000-0001-6340-457X
Osamede C OwegieBloodworks Northwest Research Institute, Seattle, WA.ORCID 0009-0009-2320-9863
Anika PatelDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
Quinn P KennedyBloodworks Northwest Research Institute, Seattle, WA.ORCID 0009-0003-2074-6176
James T FlaumenhaftDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
Mathivanan ChinnarajEdward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO.ORCID 0000-0002-7749-7364
Nathan PonzarEdward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO.ORCID 0000-0003-0624-3575
Emmy M FulcidorDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
Mario C RicoDepartment of Cardiovascular Sciences, Sol Sherry Thrombosis Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA.
Amit BhowmikDepartment of Chemistry and Biochemistry, Florida Atlantic University, Boca Raton, FL.ORCID 0009-0004-1148-2145
Kate S CarrollDepartment of Chemistry and Biochemistry, Florida Atlantic University, Boca Raton, FL.ORCID 0000-0002-7624-9617
Diane E HandyDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.ORCID 0000-0002-4310-8527
Joseph LoscalzoDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.ORCID 0000-0002-1153-8047
David W EssexDepartment of Cardiovascular Sciences, Sol Sherry Thrombosis Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA.ORCID 0000-0002-8758-0663
Nicola PozziEdward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO.ORCID 0000-0003-2309-7100
Robert FlaumenhaftDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.ORCID 0000-0001-8004-9688

Funding

PROGRAM IN BLOOD COAGULATION AND VASCULAR BIOLOGYT32HL007917 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Robert C Flaumenhaft · 1999 to 2026
$11.1M
Thiol Isomerases in Hemostasis and ThrombosisR35HL135775 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FLAUMENHAFT, ROBERT C · 2017 to 2023
$5.5M
Biomarkers and mechanisms in cancer associated thrombosisU01HL143365 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI CHAIKOF, ELLIOT, FLAUMENHAFT, ROBERT C · 2018 to 2022
$4.3M
The Transmembrane Protein Disulfide Isomerase TMX1 Negatively Regulates ThrombosisR01HL162845 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI DAVID W ESSEX · 2023 to 2026
$2.8M
Thiol Isomerases and Oxidant Stress in Thrombus FormationR01HL167383 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Robert C Flaumenhaft · 2024 to 2026
$2.0M
Structural Studies of Beta-2 glycoprotein I in the Antiphospholipid SyndromeR01HL150146 · NHLBI · SAINT LOUIS UNIVERSITY · PI POZZI, NICOLA · 2020 to 2024
$2.0M
Oxidative Cysteine Modification by Thiol Isomerases in Sickle Cell DiseaseR00HL164888 · NHLBI · BLOODWORKS · PI Moua Yang · 2024 to 2026
$747k
NHLBI NIH HHS R00 HL164888NHLBI NIH HHS R01 HL150146NHLBI NIH HHS R01 HL162845NHLBI NIH HHS R01 HL167383NHLBI NIH HHS R35 HL135775NHLBI NIH HHS T32 HL007917NHLBI NIH HHS U01 HL143365
6 · The paper itself

Abstract

abstractProtein disulfide isomerase (PDI) functions in thrombus formation in vivo and represents a viable target for antithrombotic therapy. PDI is a redox sensor that can either reduce or oxidize substrates depending on the redox environment. However, whether PDI functions primarily as a reductase or an oxidase in the context of thrombus formation remains unknown. Here, we used pharmacological and genetic approaches along with PDI mutants to determine how the PDI redox state affects thrombus formation. LOC14, which inhibits PDI reductase activity and induces PDI oxidation, promoted thrombus formation in arteries exposed to ferric chloride and enhanced laser injury-induced platelet accumulation and fibrin formation in cremaster arterioles. Blocking antibodies targeting PDI reversed the prothrombotic effect of LOC14. Evaluation of sulfenylation-mediated PDI oxidation using the C53A, C56A, R120D, and T101A PDI mutants showed that the sulfenylation mechanism of PDI resembles that of hydrogen peroxide (H2O2) reduction by peroxiredoxins. These studies identified PDI mutants that failed to undergo H2O2-mediated oxidation, but showed normal reductase activity. When tested in vivo, either wild-type PDI or the R120D mutant fully restored normal thrombus formation following morpholino-induced knockdown of PDI or in mice with platelet-specific knockout of PDI. In contrast, the sulfenylation-impaired R120D mutant PDI was unable to fully restore thrombus formation in the setting of oxidative stress induced in mice by genetic deletion of glutathione peroxidase 3 or by infusion of oxidized low-density lipoproteins. These studies show that PDI-catalyzed oxidation drives thrombosis and demonstrates a mechanism of peroxide-mediated oxidation of PDI that contributes to the prothrombotic response of oxidative stress.

Indexed as

Oxidative StressProtein Disulfide-IsomerasesThrombosisAnimalsHumansHydrogen PeroxideMiceMice, Inbred C57BLMice, KnockoutOxidation-ReductionHydrogen PeroxideProtein Disulfide-Isomerases

Identifiers

PMID41785329
PMCPMC13098563

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.